Can Genetic Instability be Therapeutically Targeted?
Yes, targeting genetic instability is an emerging strategy in cancer therapy. PARP inhibitors are drugs that exploit the defective DNA repair mechanisms in cancer cells, leading to cell death. Another approach involves using checkpoint inhibitors to enhance the immune system's ability to recognize and destroy genetically unstable cancer cells.
